Phyllodes tumor of the breast

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:180261D48.6
Who is this for?
Show terms as
17Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Phyllodes tumor of the breast (also known as cystosarcoma phyllodes or phylloides tumor) is a rare fibroepithelial neoplasm of the breast that arises from the periductal stromal cells. These tumors account for less than 1% of all breast neoplasms and are classified by the World Health Organization into three categories: benign, borderline, and malignant, based on histological features including stromal cellularity, mitotic activity, stromal overgrowth, and tumor margins. Phyllodes tumors predominantly affect women, with a peak incidence in the fourth and fifth decades of life, though they can occur at any age after puberty. The most common clinical presentation is a rapidly growing, firm, well-circumscribed breast mass that may become quite large. Patients typically notice a painless lump that increases in size over weeks to months. Large tumors may cause skin stretching, visible veins, and occasionally skin ulceration. Unlike breast carcinomas, phyllodes tumors rarely spread to axillary lymph nodes, but malignant variants can metastasize hematogenously, most commonly to the lungs, bones, and liver. The primary treatment for phyllodes tumors is wide local excision with adequate surgical margins, as local recurrence is a significant concern, particularly with borderline and malignant subtypes. Mastectomy may be necessary for large tumors or when adequate margins cannot be achieved with breast-conserving surgery. The role of adjuvant radiation therapy remains debated but may be considered for borderline and malignant tumors to reduce local recurrence risk. Chemotherapy has limited efficacy and is generally reserved for metastatic disease. Most phyllodes tumors are sporadic, though rare associations with Li-Fraumeni syndrome (TP53 mutations) have been reported. Prognosis is generally favorable for benign and borderline tumors, while malignant phyllodes tumors carry a more guarded prognosis with potential for distant metastasis.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Mar 2023AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Phyllodes tumor of the breast.

View clinical trials →

No actively recruiting trials found for Phyllodes tumor of the breast at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Phyllodes tumor of the breast community →

Specialists

17 foundView all specialists →
LP
Liron Pantanowitz
ANN ARBOR, MI
Specialist
1 Phyllodes tumor of the breast publication
LN
Luca Nicosia
Specialist
1 Phyllodes tumor of the breast publication
EC
Enrico Cassano
Specialist
1 Phyllodes tumor of the breast publication
AA
Arwa Ahmed Ashoor
Specialist
1 Phyllodes tumor of the breast publication
JH
Jason L Hornick
BOSTON, MA
Specialist
1 Phyllodes tumor of the breast publication
ER
Esther Diana Rossi
Specialist
1 Phyllodes tumor of the breast publication
AS
Angela Santoro
CHERRY HILL, NJ
Specialist
1 Phyllodes tumor of the breast publication
AH
Atif A Hashmi
DAYTON, OH
Specialist
2 Phyllodes tumor of the breast publications
GL
Germana Lissidini
Specialist
1 Phyllodes tumor of the breast publication
AM
Antonino Mulè
Specialist
1 Phyllodes tumor of the breast publication
GP
Giovanni Papa
Specialist
1 Phyllodes tumor of the breast publication
RS
Ronaldo Pereira Souza
Specialist
1 Phyllodes tumor of the breast publication
MD
Mauricio Doi
Specialist
1 Phyllodes tumor of the breast publication
MB
Marina De Brot
Specialist
1 Phyllodes tumor of the breast publication
&F
Ângelo Bezerra de Souza Fede
Specialist
1 Phyllodes tumor of the breast publication
MA
Mohamed Ah Mansour, ass.prof
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Phyllodes tumor of the breast.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Phyllodes tumor of the breastForum →

No community posts yet. Be the first to share your experience with Phyllodes tumor of the breast.

Start the conversation →

Latest news about Phyllodes tumor of the breast

Disease timeline:

New recruiting trial: AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors

A new clinical trial is recruiting patients for Phyllodes tumor of the breast

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Phyllodes tumor of the breast

What is Phyllodes tumor of the breast?

Phyllodes tumor of the breast (also known as cystosarcoma phyllodes or phylloides tumor) is a rare fibroepithelial neoplasm of the breast that arises from the periductal stromal cells. These tumors account for less than 1% of all breast neoplasms and are classified by the World Health Organization into three categories: benign, borderline, and malignant, based on histological features including stromal cellularity, mitotic activity, stromal overgrowth, and tumor margins. Phyllodes tumors predominantly affect women, with a peak incidence in the fourth and fifth decades of life, though they can

How is Phyllodes tumor of the breast inherited?

Phyllodes tumor of the breast follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Phyllodes tumor of the breast typically begin?

Typical onset of Phyllodes tumor of the breast is adult. Age of onset can vary across affected individuals.

Which specialists treat Phyllodes tumor of the breast?

17 specialists and care centers treating Phyllodes tumor of the breast are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.